Zevra Therapeutics: Funding, Investors & Team (Sep 2026)
Zevra Therapeutics is a company that is in the process of developing new pharmaceuticals in the fields of pain management, ADHD, and other CNS disorders. The company's main focus is on creating safer opioid pain relievers that are resistant to abuse. Zevra Therapeutics utilizes its Ligand Activated Therapy (LAT) approach for drug discovery and development. KemPharm, the company behind Zevra Therapeutics, employs patented technology to enhance current medications and speed up the development process, all while retaining a solid intellectual property stance in each therapeutic field.
Zevra Therapeutics has raised $120M across 2 funding rounds on record, the most recent an undisclosed round of $60.0M announced in Aug 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zevra Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Zevra Therapeutics Funding Rounds
Zevra Therapeutics raised $60.0M in an undisclosed round announced in Apr 2024.
4 months later, an undisclosed round of $60.0M was announced in Aug 2024.
Zevra Therapeutics Founders and Leadership Team
Contact details for the Zevra Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Zevra Therapeutics Funding Compared to Other Biotechnology Startups
Zevra Therapeutics' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zevra Therapeutics in Biotechnology and Orlando
Companies Similar to Zevra Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Zevra Therapeutics Funding FAQs
What does Zevra Therapeutics do?
Zevra Therapeutics is a company that is in the process of developing new pharmaceuticals in the fields of pain management, ADHD, and other CNS disorders. The company's main focus is on creating safer opioid pain relievers that are resistant to abuse. Zevra Therapeutics utilizes its Ligand Activated Therapy (LAT) approach for drug discovery and development. KemPharm, the company behind Zevra Therapeutics, employs patented technology to enhance current medications and speed up the development process, all while retaining a solid intellectual property stance in each therapeutic field.
How much funding has Zevra Therapeutics raised?
Zevra Therapeutics has raised $120M across 2 rounds on record. The most recent is an undisclosed round of $60.0M announced in Aug 2024.
When did Zevra Therapeutics last raise funding?
Zevra Therapeutics' most recent funding round on record is an undisclosed round of $60.0M, announced in Aug 2024.
Who founded Zevra Therapeutics?
FundedIQ lists Travis C Mickle (Founder) at Zevra Therapeutics.
Where is Zevra Therapeutics headquartered?
Zevra Therapeutics is based in Orlando, Florida, United States.
How many employees does Zevra Therapeutics have?
Zevra Therapeutics is in the 51-100 employee band.
How does Zevra Therapeutics' funding compare to other Biotechnology startups?
Zevra Therapeutics' latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Zevra Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zevra Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.